Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Beck

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
NPJ Genomic Medicine|November 25, 2021
Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
NPJ Genomic Medicine|November 9, 2021
Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
American Journal of Medical Genetics. Part A|February 1, 2021
Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesKevin E Glinton, Anna C E Hurst, Kevin M Bowling, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Nature Immunology|April 12, 2024
Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiencyHirotsugu Oda, Kalpana Manthiram, Pallavi Pimpale Chavan, et al.
Blood|April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromesMaria Sirenko, Elsa Bernard, Maria Creignou, et al.
Nature|December 13, 2019
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNajoua Lalaoui, Steven E Boyden, Hirotsugu Oda, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
NPJ Genomic Medicine|November 25, 2021
Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
NPJ Genomic Medicine|November 9, 2021
Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
American Journal of Medical Genetics. Part A|February 1, 2021
Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesKevin E Glinton, Anna C E Hurst, Kevin M Bowling, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Nature Immunology|April 12, 2024
Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiencyHirotsugu Oda, Kalpana Manthiram, Pallavi Pimpale Chavan, et al.
Blood|April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromesMaria Sirenko, Elsa Bernard, Maria Creignou, et al.
Nature|December 13, 2019
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNajoua Lalaoui, Steven E Boyden, Hirotsugu Oda, et al.
Pageof 9